What is Ampronix?
Ampronix stands as a distinguished authorized master distributor for leading medical industry brands and a world-class manufacturer of innovative technology. Established in 1982, the company has consistently addressed the evolving demands of the medical community through its profound product knowledge, exceptional service, and advanced repair facilities. Ampronix specializes in delivering customized, comprehensive solutions that are both more efficient and cost-effective than those offered by competitors. Its commitment to quality is validated by certifications including ISO 13485:2003, ISO 9001:2008, and ANSI/ESD S20.20-2007, solidifying its reputation as a reliable partner in medical device distribution and manufacturing.
How much funding has Ampronix raised?
Ampronix has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Ampronix?
With the recent influx of capital, Ampronix is poised for accelerated expansion and further innovation in the medical technology market. The substantial backing, characterized as a major strategic investment, suggests a focus on scaling operations, enhancing its product portfolio, and potentially exploring new market segments. This late-stage funding indicates a mature company ready to leverage its established infrastructure and market presence for significant growth. Future developments are likely to involve strategic partnerships, advancements in manufacturing capabilities, and the continued delivery of tailored, cost-effective solutions to the global medical community, reinforcing its competitive edge.
See full Ampronix company page
